Acro Biomedical Co (ACBM) Stock Statistics & Valuation Metrics

Acro Biomedical Co has a market cap or net worth of $1.56M. The enterprise value is $1.93M.

Acro Biomedical Co has 60,042,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Acro Biomedical Co’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is 250.64%.

The current PE Ratio of Acro Biomedical Co is ―. Acro Biomedical Co’s PEG ratio is -0.09.

In the last 12 months, Acro Biomedical Co had revenue of 0.00 and earned -101.15K in profits. Earnings per share was >-0.01.

In the last 12 months, operating cash flow was -140.11K and capital expenditures -3.00, giving a free cash flow of -140.12K billion.

Acro Biomedical Co pays an annual dividend of ―, resulting in a dividend yield of ―

Acro Biomedical Co upcoming earnings date is Feb 15, 2018, Before Open (Confirmed).

Acro Biomedical Co as a current ratio of 0.04, with Debt / Equity ratio of -86.64%

In the past 12 months, Acro Biomedical Co has paid 0.00 in taxes.

Acro Biomedical Co EV to EBITDA ratio is -10.74, with an EV/FCF ratio of -8.43.

Acro Biomedical Co has $3.65K in cash and marketable securities with $385.39K in debt, giving a net cash position of -$381.74K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Acro Biomedical Co is ―, which is 11.43% higher than the current price. The consensus rating is ―